Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-cash Items (2020 - 2023)

Historic Non-cash Items for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to -$33499.0.

  • ADC Therapeutics' Non-cash Items fell 34505.49% to -$33499.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$112906.0, marking a year-over-year increase of 1010.24%. This contributed to the annual value of -$71082.0 for FY2022, which is 6643.67% up from last year.
  • Per ADC Therapeutics' latest filing, its Non-cash Items stood at -$33499.0 for Q3 2023, which was down 34505.49% from -$37509.0 recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Non-cash Items registered a high of $13670.0 during Q3 2022, and its lowest value of -$39.4 million during Q1 2020.
  • For the 4-year period, ADC Therapeutics' Non-cash Items averaged around -$3.3 million, with its median value being -$42655.5 (2021).
  • Per our database at Business Quant, ADC Therapeutics' Non-cash Items soared by 13176.56% in 2022 and then crashed by 34505.49% in 2023.
  • Over the past 4 years, ADC Therapeutics' Non-cash Items (Quarter) stood at -$39.4 million in 2020, then surged by 99.86% to -$54133.0 in 2021, then soared by 100.7% to $379.0 in 2022, then crashed by 8938.79% to -$33499.0 in 2023.
  • Its last three reported values are -$33499.0 in Q3 2023, -$37509.0 for Q2 2023, and -$42277.0 during Q1 2023.